Literature DB >> 8380292

Virus-specific antibody responses in mothers and their newborn infants with asymptomatic congenital cytomegalovirus infections.

S B Boppana1, R F Pass, W J Britt.   

Abstract

Human cytomegalovirus (HCMV)-specific antibody response was analyzed to determine its relationship with sequelae in children with asymptomatic congenital HCMV infection. IgG antibodies reactive with envelope glycoprotein gB were significantly higher in cord and maternal delivery serum of infants developing hearing loss than in those without any sequelae. Women of hearing impaired children had higher levels of serum anti-gB IgG and HCMV IgM at first prenatal visit (8-16 weeks gestation) than did those with children with normal hearing. Kinetics of the antibody response revealed that women with hearing impaired children had peak anti-gB and IgM response at the first prenatal visit compared with at or near delivery in mothers of normal children. These results suggested that women who delivered infants developing hearing loss had a more intense and prolonged antibody response, and factors such as early virus acquisition during pregnancy might contribute to the development of sequelae in asymptomatic congenital HCMV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380292     DOI: 10.1093/infdis/167.1.72

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts.

Authors:  D G Hemmings; R Kilani; C Nykiforuk; J Preiksaitis; L J Guilbert
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus.

Authors:  Caroline Breese Hall; Mary T Caserta; Kenneth C Schnabel; Lynne M Shelley; Jennifer A Carnahan; Andrea S Marino; Christina Yoo; Geraldine K Lofthus
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

3.  Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.

Authors:  Getachew Sequar; William J Britt; Fred D Lakeman; Kristen M Lockridge; Ross P Tarara; Don R Canfield; Shan-Shan Zhou; Murray B Gardner; Peter A Barry
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 4.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 5.  Congenital and perinatal infections: throwing new light with an old TORCH.

Authors:  Anita Shet
Journal:  Indian J Pediatr       Date:  2010-10-16       Impact factor: 5.319

6.  Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination.

Authors:  Fengsheng Li; Daniel C Freed; Aimin Tang; Richard R Rustandi; Matthew C Troutman; Amy S Espeseth; Ningyan Zhang; Zhiqiang An; Michael McVoy; Hua Zhu; Sha Ha; Dai Wang; Stuart P Adler; Tong-Ming Fu
Journal:  NPJ Vaccines       Date:  2017-12-14       Impact factor: 7.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.